Newswire (Published: Friday, June 9, 2017, Received: Friday, June 2, 2017, 2:14:14 AM CDT)

Word Count: 391

By a News Reporter-Staff News Editor at Drug Week -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting originating in London, United Kingdom, by NewsRx journalists, research stated, "To investigate the risk of thromboembolic disease (TED) after radiation therapy (RT) with curative intent for prostate cancer (PCa). We identified all men who received RT as curative treatment (n=9410) and grouped according to external beam RT (EBRT) or brachytherapy (BT)."

The news reporters obtained a quote from the research from King's College London, "By comparing with an age-and county-matched comparison cohort of PCa-free men (n = 46,826), we investigated risk of TED after RT using Cox proportional hazard regression models. The model was adjusted for tumor characteristics, demographics, comorbidities, PCa treatments, and known risk factors of TED, such as recent surgery and disease progression. Between 2006 and 2013, 6232 men with PCa received EBRT, and 3178 underwent BT. A statistically significant association was found between EBRT and BT and risk of pulmonary embolism in the crude analysis. However, upon adjusting for known TED risk factors these associations disappeared. No significant associations were found between BT or EBRT and deep venous thrombosis."

According to the news reporters, the research concluded: "Curative RT for prostate cancer using contemporary methodologies was not associated with an increased risk of TED."

For more information on this research see: Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events. International Journal of Radiation Oncology Biology Physics, 2017;97(5):1026-1031. International Journal of Radiation Oncology Biology Physics can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA (see also Oncology - Prostate Cancer).

Our news correspondents report that additional information may be obtained by contacting C. Bosco, Kings Coll London, Div Canc Studies, TOUR, London, United Kingdom. Additional authors for this research include H. Garmo, J. Adolfsson, P. Stattin, L. Holmberg, P. Nilsson, A. Gunnlaugsson, A. Widmark and M. Van Hemelrijck.

Keywords for this news article include: London, United Kingdom, Europe, Lung Diseases and Conditions, Cancer, Epidemiology, Drugs and Therapies, Risk and Prevention, Prostatic Neoplasms, Pulmonary Embolism, Radiation Therapy, Prostate Cancer, Oncology, King's College London.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

King's College London

Places

North America
Northern Europe
United Kingdom
United States
Americas
Europe
England
New York
London
New York City

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Medical Specialties and Practices
            Radiology
      Treatments and Therapies
            Radiation Therapy